Ghrelin inhibits inflammatory pain in rats: Involvement of the opioid system

Neuropharmacology

Volumn 51, Issue 3, 2006, Pages 497-505

  Sibilia, Valeria ^a   Lattuada, Norma ^a   Rapetti, Daniela ^b   Pagani, Francesca ^a   Vincenza, DeLuca ^a   Bulgarelli, Ilaria ^b   Locatelli, Vittorio ^b   Guidobono, Francesca ^a   Netti, Carmela ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Edema; Ghrelin; Hyperalgesia; Opioid system; Randall Selitto

Indexed keywords

17 METHYLNALOXONE; CARRAGEENAN; GHRELIN; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EDEMA; HYPERALGESIA; INFLAMMATION; MALE; NONHUMAN; PAIN ASSESSMENT; PAW EDEMA; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CARRAGEENAN; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG INTERACTIONS; EDEMA; GENE EXPRESSION REGULATION; GHRELIN; MALE; NALOXONE; NARCOTIC ANTAGONISTS; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PEPTIDE HORMONES; PRO-OPIOMELANOCORTIN; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 33747083179     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.04.009     Document Type: Article

References (39)

1. Banks W.A., Tschop M., Robinson S.M., and Heiman M.L. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. Journal of Pharmacology and Experimental Therapeutics 302 (2002) 822-827
2. Bhattacharya S.K., Das N., and Rao P.J.R. Brain monoamines during carrageenan-induced acute paw inflammation in rats. Journal of Pharmacy and Pharmacology 40 (1988) 518-520
3. Bloom F., Battenberg E., Rossier J., Ling N., and Guillemin R. Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies. Proceedings of the National Academy of Sciences of the United States of America 75 (1978) 1591-1595
4. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 (1987) 156-159
5. Cowley M.A., Smith R.G., Diano S., Tschop M., Pronchuk N., Grove K.L., Strasburger C.J., Bidlingmaier M., Esterman M., Heiman M.L., Garcia-Segura L.M., Nillni E.A., Mendez P., Low M.J., Sotonyi P., Friedman J.M., Liu H., Pinto S., Colmers W.F., Cone R.D., and Horvath T.L. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37 (2003) 649-661
6. Daher J.B., and Tonussi C.R. A spinal mechanism for the peripheral anti-inflammatory action of indomethacin. Brain Research 962 (2003) 207-212
7. Dixit V.D., Schaffer E.M., Pyle R.S., Collins G.D., Sakthivel S.K., Palaniappan R., Lillard Jr. J.W., and Taub D.D. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. Journal of Clinical Investigation 114 (2004) 57-66
8. Furst S., Riba P., Friedmann T., Timar J., Al-Khrasani M., Obara I., Makuch W., Spetta M., Schutz J., Pzewlocki R., Przewlocka B., and Schmidhammer H. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-o-methyloxymorphone in acute and inflammatory pain in the rat. Journal of Pharmacology and Experimental Therapeutics 312 (2005) 609-618
9. Gaskin F.S., Farr S.A., Banks W.A., Kumar V.B., and Morley J.E. Ghrelin-induced feeding is dependent on nitric oxide. Peptides 24 (2003) 913-918
10. Granado M., Priego T., Martin A.I., Villanua M.A., and Lopez-Calderon A. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. American Journal of Physiology - Endocrinology and Metabolism 288 (2005) E486-E492
11. Guan X.M., Yu H., Palyha O.C., McKee K.K., Feighner S.D., Sirinathsinghji D.J., Smith R.G., Van der Ploeg L.H., and Howard A.D. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Research Molecular Brain Research 48 (1997) 23-29
12. 2 synthase-1. Journal of Biological Chemistry 279 (2004) 24866-24872
13. Guidobono F., Netti C., Villani P., Bettica P., and Pecile A. Antinociceptive activity of eel calcitonin, injected into the inflamed paw in rats. Neuropharmacology 30 (1991) 1275-1278
14. Hataya Y., Akamizu T., Hosoda H., Kanamoto N., Moriyama K., Kangawa K., Takaya K., and Nakao K. Alterations of plasma ghrelin levels in rats with lipopolysaccharide-induced wasting syndrome and effects of ghrelin treatment on the syndrome. Endocrinology 144 (2003) 5365-5371
15. Heinzen E.L., Booth R.G., and Pollack G.M. Neuronal nitric oxide modulates morphine antinociceptive tolerance by enhancing constitutive activity of the mu-opioid receptor. Biochemical Pharmacology 69 (2005) 679-688
16. Hewson A.K., and Dickson S.L. Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. Journal of Neuroendocrinology 12 (2000) 1047-1049
17. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., and Wakabayashi I. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 141 (2000) 4797-4800
18. Kayser V., and Guilbaud G. Differential effects of various doses of morphine and naloxone on two nociceptive test thresholds in arthritic and normal rats. Pain 41 (1990) 353-363
19. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
20. Kojima M., and Kangawa K. Ghrelin: structure and function. Physiological Reviews 85 (2005) 495-522
21. Korbonits M., Goldstone A.P., Gueorguiev M., and Grossman A.B. Ghrelin - a hormone with multiple functions. Frontiers in Neuroendocrinology 25 (2004) 27-68
22. Lawrence C.B., Snape A.C., Baudoin F.M., and Luckman S.M. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centres. Endocrinology 143 (2002) 155-162
23. Li W.G., Gavrila D., Liu X., Wang L., Gunnlaugsson S., Stoll L.L., McCormick M.L., Sigmund C.D., Tang C., and Weintraub N.L. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 109 (2004) 2221-2226
24. Monroe P.J., Hawranko A.A., Smith D.L., and Smith D.J. Biochemical and pharmacological characterization of multiple beta-endorphinergic antinociceptive systems in the rat periaqueductal gray. Journal of Pharmacology and Experimental Therapeutics 276 (1996) 65-73
25. Netti C., Bossa R., Galatulas I., Sibilia V., and Pecile A. Antinociceptive effect of centrally administered cimetidine and dimaprit in the rat. Pharmacology 28 (1984) 262-267
26. Netti C., Sibilia V., Guidobono F., Villani P., Pecile A., and Braga P.C. Evidence for an inhibitory role of central histamine on carrageenin-induced hyperalgesia. Neuropharmacology 33 (1994) 205-210
27. Porro C.A., Tassinari G., Facchinetti F., Panerai A.E., and Carli G. Central beta-endorphin system involvement in the reaction to acute tonic pain. Experimental Brain Research 83 (1991) 549-554
28. Randall L.O., and Selitto J.J. A method for measurement of analgesic activity on inflamed tissue. Archives Internationales de Pharmacodynamie et de Therapie 111 (1957) 409-419
29. Riediger T., Traebert M., Schmid H.A., Scheel C., Lutz T.A., and Scharrer E. Site-specific effects of ghrelin on the neuronal activity in the hypothalamic arcuate nucleus. Neuroscience Letters 341 (2003) 151-155
30. Ruter J., Kobelt P., Tebbe J.J., Avsar Y., Veh R., Wang L., Klapp B.F., Wiedenmann B., Taché Y., and Monnikes H. Intraperitoneal injection of ghrelin induces Fos expression in the paraventricular nucleus of the hypothalamus in rats. Brain Research 991 (2003) 26-33
31. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S., Bonventre J.V., and Woolf C.J. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410 (2001) 471-475
32. Sevostianova N., Danysz W., and Bespalov A.Y. Analgesic effects of morphine and loperamide in the rat Formalin test: interactions with NMDA receptor antagonists. European Journal of Pharmacology 525 1-3 (2005) 83-90
33. Sun Y.G., Lundeberg T., and Yu L.C. Involvement of endogenous beta-endorphin in antinociception in the arcuate nucleus of hypothalamus in rats with inflammation. Pain 104 (2003) 55-63
34. Taiwo Y.O., Coderre T.J., and Levine J.D. The contribution of training to sensitivity in the nociceptive paw-withdrawal test. Brain Research 487 (1989) 148-151
35. Umeno H., Nagasawa T., Yamazaki N., and Kuraishi Y. Antinociceptive effects of repeated systemic injections of calcitonin in formalin-induced hyperalgesic rats. Pharmacology Biochemistry and Behavior 55 (1996) 151-156
36. Whiteside G.T., Boulet J.M., and Walker K. The role of central and peripheral mu opioid receptors in inflammatory pain and edema: a study using morphine and DipOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-3-yl]-acetic acid). Journal of Pharmacology and Experimental Therapeutics 314 (2005) 1234-1240
37. Zangen A., Herzberg U., Vogel Z., and Yadid G. Nociceptive stimulus induces release of endogenous beta-endorphin in the rat brain. Neuroscience 85 (1998) 659-662
38. Zigman J.M., Jones J.E., Lee C.E., Saper C.B., and Elmquist J.K. Expression of ghrelin receptor mRNA in the rat and mouse brain. Journal of Comparative Neurology 548 (2006) 528-548
39. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110